BGB-3111: Additional Ph I data

Data from 46 evaluable patients with chronic lymphocytic lymphoma (CLL) or small lymphocytic leukemia (SLL) in an open-label, dose-escalation, international Phase I trial showed that

Read the full 256 word article

User Sign In